Koninklijke Philips N.V. NY Registry Shares

Stage 4 · Declining · week 6

As of Oct 22, 2026, Koninklijke Philips N.V. NY Registry Shares is in Stage 4, the downtrend phase, now in week 6 (since Sep 15, 2026). It closed at $26.92, 15.0% below its 52-week high and above its 200-day average, which is falling.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. More about the company

$26.92

+2.55% today

$26.3B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PHG early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 28w

S2 17w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 6w → S3 9w → S4 2w → S1 1w → S2 10w → S3 4w → S4 5w → S1 1w → S2 28w → S3 7w → S4 6w → S1 8w → S4 12w → S1 6w → S2 17w → S3 5w → S2 10w → S3 5w → S4 10w → S1 9w → S4 5w current

Total tracked: 166 weeks across 21 stage runs.

PHG among Medical Devices46th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…46	PHGKoninklijke Philips N.V. NY Registry Shares	Stage 4 · wk 6	53	+10.1%

vs 52W High

-15.0%

$23.81 lo$31.68 hi

15.0% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

0.4%

200 DMA: $26.82 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.30x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↗ ⇈

Short-term trend rising gently, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+10.1%

+2.9%

+1.2%

YTD

+3.3%

-1.5%

Scan Membership

Breakout Watch

Latest: 2024-05-03

8 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 6 · Vol 1.30x

2026-10-21S4

Wk 6 · Vol 0.96x

2026-10-20S4

Wk 6 · Vol 0.87x

2026-10-19S4

Wk 5 · Vol 1.21x

2026-10-16S4

Wk 5 · Vol 1.47x

2026-10-15S4

Wk 5 · Vol 1.36x

2026-10-14S4

Wk 5 · Vol 1.23x

2026-10-13S4

Wk 5 · Vol 1.09x

2026-10-12S4

Wk 4 · Vol 1.34x

2026-10-09S4

Wk 4 · Vol 3.83x

2026-10-08S4

Wk 4 · Vol 1.88x

2026-10-07S4

Wk 4 · Vol 1.59x

Moving averages & range

50 DMA

$25.58

200 DMA

$26.82

52W High

$31.68

52W Low

$23.81

5D Low

$25.50

Resistance levels (recent highs)

20d High

$26.92

60d High

$27.62

120d High

$28.23

250d High

$31.68

Next resistance

+2.6%

to 60d High

P/E (TTM)

20.1

Forward 14.2

Earnings Growth (YoY)

+61.4%

Revenue +0.5%

ROE

+10.2%

Profit margin +6.3%

Dividend Yield

3.86%

P/B 2.0

Koninklijke Philips N.V. NY Registry Shares: quick answers

What stage is Koninklijke Philips N.V. NY Registry Shares in?

As of Oct 22, 2026, Koninklijke Philips N.V. NY Registry Shares (PHG) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 15, 2026 and is in week 6. What the four stages mean

Is Koninklijke Philips N.V. NY Registry Shares in an uptrend?

No. Koninklijke Philips N.V. NY Registry Shares is in a Stage 4 downtrend. It trades 0.4% above its 200-day average, which is falling.

How far is Koninklijke Philips N.V. NY Registry Shares from its 52-week high?

Koninklijke Philips N.V. NY Registry Shares closed at $26.92 on Oct 22, 2026, 15.0% below its 52-week high of $31.68. Its 52-week low is $23.81.

How has Koninklijke Philips N.V. NY Registry Shares performed over the past year?

As of Oct 22, 2026, Koninklijke Philips N.V. NY Registry Shares is down 1.5% over the past year and up 3.3% so far in 2026.

Which sector and industry is Koninklijke Philips N.V. NY Registry Shares in?

Koninklijke Philips N.V. NY Registry Shares is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.